Erectile Dysfunction: Your Heart's Early Warning Signal
Dr Ben Davis | MRCGP · MRCP · FECSM · RegCOSRT · PhD (Men's Health)
GP, Men's Health Physician and COSRT-registered Psychosexual and Relationship Therapist
Central Health London, Devonshire Place, Marylebone
Most men who come to see me about erectile dysfunction are thinking about their sex lives. Very few are thinking about their heart. In many cases, they should be thinking about both — because the connection between erection problems and cardiovascular disease is one of the most clinically significant and least communicated findings in men's health.
This is not a niche observation. It is supported by decades of research, multiple major meta-analyses, and the most recent international consensus guidelines on sexual medicine and cardiac risk. And yet most men with erection problems are either handed a prescription for Viagra or sent away, without anyone having asked about their cardiovascular health at all.
This is exactly the kind of problem my practice is built around: I'm able to assess the cardiovascular, hormonal and psychological dimensions of erection problems in a single consultation — more on how, below.
The Artery Size Hypothesis: Why ED Comes First
To understand why erection problems can be an early warning sign of heart disease, you need to understand the anatomy.
The penile arteries — the vessels that supply blood flow to the penis during an erection — are small. Around 1 to 2 millimetres in diameter. The coronary arteries that supply the heart are larger — roughly 3 to 4 millimetres across.
When atherosclerosis develops — the process in which fatty plaques accumulate on the inner walls of blood vessels, reducing their elasticity and narrowing their diameter — the smaller vessels are affected first. The same pathological process that will, years later, compromise blood flow to the heart, tends to show up first in the smaller penile vessels. The result is an erection problem that precedes any cardiac symptoms, sometimes by a significant margin.
If reading that makes you anxious, hold onto the other side of it: this is precisely why erection problems are so useful as a signal. They give you a two-to-five-year head start on a problem that is very treatable when caught early. Men who act on that signal are in a far better position than men who never get one at all.
This hypothesis, often called the "artery size hypothesis," was first formalised in a landmark review and has since been consistently supported by longitudinal studies showing that erectile dysfunction often precedes the clinical diagnosis of cardiovascular disease by two to five years.1,2
The Second Princeton Consensus Conference — a multispecialty expert panel on sexual dysfunction and cardiac risk — concluded that a man presenting with erectile dysfunction and no cardiac symptoms should be considered a cardiac or vascular patient until proven otherwise.3
What the Evidence Shows
The evidence linking erectile dysfunction to cardiovascular risk is now substantial, spanning hundreds of thousands of participants across multiple study designs.
A widely cited meta-analysis published in the Journal of the American College of Cardiology — covering twelve prospective cohort studies and over 36,000 participants — found that men with erectile dysfunction had a 48% higher relative risk of cardiovascular disease, a 46% higher risk of coronary heart disease, a 35% higher risk of stroke, and a 19% higher risk of all-cause mortality, compared with men without erectile dysfunction. Critically, these associations held even after controlling for conventional cardiovascular risk factors such as age, blood pressure, cholesterol, smoking status and diabetes.4
A larger subsequent meta-analysis in Circulation: Cardiovascular Quality and Outcomes — covering over 92,000 subjects — confirmed these findings, and additionally showed that the relative risk was highest in younger men, underscoring that erectile dysfunction in your 30s and 40s carries particular significance as a cardiovascular signal.5
A 2024 systematic review and meta-analysis encompassing over 450,000 participants found that men with erectile dysfunction had roughly one and a half times the odds of cardiovascular disease compared with men without — with longitudinal data consistently demonstrating that erectile dysfunction precedes cardiovascular diagnosis by two to five years.6 (This analysis is currently available as a preprint, though its findings are consistent with the peer-reviewed literature above.)
The most recent international expert statement — the Princeton IV Consensus Conference, convened in March 2023 — went further, recommending that erectile dysfunction be formally recognised as a cardiovascular risk-enhancing factor, and that coronary artery calcium (CAC) scoring be offered to men with erectile dysfunction who fall into low-to-intermediate cardiovascular risk categories to better stratify their actual risk.7
Shared Biology: Endothelial Dysfunction
The mechanism linking these two conditions is not coincidental. Both erectile dysfunction and cardiovascular disease share a fundamental underlying process: endothelial dysfunction.
The endothelium is the thin layer of cells lining the interior surface of blood vessels. Healthy endothelial function regulates vascular tone, controls blood flow, and — critically — produces nitric oxide, the chemical messenger that relaxes smooth muscle in vessel walls and allows blood to flow.
In erectile function, nitric oxide is central. Sexual arousal triggers its release in the penile vasculature, relaxing the smooth muscle of the cavernous arteries and allowing the inflow of blood that produces an erection. When endothelial function is compromised — by smoking, diabetes, hypertension, dyslipidaemia, obesity, or chronic inflammation — this nitric oxide signalling is impaired. The same impairment that diminishes erectile response also progresses, over time, to structural vascular disease elsewhere.
This is why erectile dysfunction and cardiovascular disease are not merely correlated by shared risk factors. They share a common pathophysiology. Erectile dysfunction is, in many cases, an early-stage expression of systemic vascular disease that has not yet reached the coronary circulation.
Who Is Most at Risk?
Erectile dysfunction in younger men — particularly those in their 40s and 50s with no obvious cardiac history — deserves the most careful cardiovascular evaluation.
This may seem counterintuitive. Older men are more likely to have cardiovascular disease in absolute terms. But the relative signal that erectile dysfunction carries is strongest in younger men, precisely because alternative explanations are fewer. In a 70-year-old man with hypertension, diabetes and obesity, erection problems are expected. In a 44-year-old who appears well and has no known risk factors, they are a meaningful clinical signal — one that warrants investigation rather than a prescription for sildenafil and reassurance.
Men with erectile dysfunction who also have diabetes face a compounded risk. A meta-analysis of diabetic men with erectile dysfunction found a 74% higher odds of cardiovascular events compared with diabetic men without erectile dysfunction.8
The severity of erectile dysfunction also correlates with the severity of underlying coronary artery disease. More severe erection problems tend to reflect more advanced vascular pathology — a dose-response relationship that strengthens the argument for erectile dysfunction as a cardiovascular biomarker rather than simply a comorbidity.2
What a Proper Assessment Should Look Like
If you present with erectile dysfunction and someone simply hands you a Viagra prescription without asking about your cardiovascular health, something has been missed.
A proper assessment of erection problems in a man over 40 should include:
Clinical assessment
Blood pressure (ideally with home monitoring to exclude white-coat hypertension)
Waist circumference and BMI
Personal and family history of cardiovascular disease
Smoking and alcohol history
Exercise tolerance and functional capacity
Blood tests
Fasting lipid profile, including LDL, HDL, triglycerides and — importantly — lipoprotein(a) and ApoB, which are not included in standard panels but are independent cardiovascular risk factors
HbA1c and fasting glucose
High-sensitivity CRP (hsCRP), a marker of vascular inflammation
Testosterone, male hormone profile and thyroid function
Imaging, where indicated
CT coronary artery calcium (CAC) score: A non-invasive, low-radiation scan that directly measures arterial calcification. This is currently the most cost-effective way to identify subclinical coronary artery disease before symptoms appear, and is now explicitly recommended by the Princeton IV guidelines for men with erectile dysfunction who fall into low-to-intermediate cardiovascular risk categories.
CT coronary angiogram: Where calcification is found or clinical suspicion is higher, this gives a more detailed anatomical picture of the coronary arteries.
Consideration of night time erection tracking
This approach can identify significant, treatable cardiovascular disease before a heart attack or stroke occurs. That is the purpose of taking erection problems seriously as a clinical signal — not because they are trivial, but because they may point to something that is not.
A Note on Treatment
Treating the cardiovascular risk does not mean ignoring the erectile dysfunction. Both deserve attention, and addressing one frequently helps the other.
Lifestyle interventions that reduce cardiovascular risk — regular aerobic exercise, smoking cessation, dietary change, weight loss — also improve erectile function, often substantially. In men where metabolic dysfunction underlies both problems, addressing obesity, sleep apnoea and physical inactivity can restore both testosterone and erectile function without medication.
PDE5 inhibitors (sildenafil, tadalafil) are the first-line medical treatment for erectile dysfunction, and there is growing evidence from recent meta-analyses that these medications may carry additional cardioprotective benefits for some men — though this is not yet established as a clinical indication for their use.9
Where significant cardiovascular disease is identified, management is coordinated with a cardiologist. The Princeton IV guidelines provide clear guidance on which men with known cardiac disease can safely engage in sexual activity and receive treatment for erectile dysfunction, and when specialist cardiology input is needed first.
What I Do Differently
Most men with erection problems need more than one kind of help — and most services offer only one kind.
A GP without specialist training may prescribe Viagra and miss the cardiovascular picture entirely. A sex therapist addresses the psychological and relational dimensions but cannot investigate vascular risk or hormone levels. A testosterone clinic looks at hormones but rarely at the heart, the relationship, or the anxiety loop that often sustains erection problems long after the physical trigger has resolved.
I hold all of these together. As a GP, a physician trained in internal medicine, a specialist in sexual medicine (FECSM), and a COSRT-registered psychosexual and relationship therapist — based at Central Health London in Marylebone — I can assess cardiovascular risk and psychosexual function in the same consultation, with the same clinician, without referring you elsewhere for the parts that don't fit a single specialty.
In practice, this means most consultations cover both dimensions. What's happening physiologically — blood flow, hormone levels, cardiovascular markers — and what's happening psychologically: the anxiety, the self-monitoring, the relational dynamics that almost always develop around erection difficulties over time, even when the original cause was physical.
If I identify cardiovascular risk that warrants further investigation, I arrange it directly — CT calcium scoring, extended lipid panels including lipoprotein(a) and ApoB, CT coronary angiography, and cardiology referral where appropriate. I remain your central point of contact throughout, so that results are explained clearly and nothing falls between specialties.
If your erection problems have been treated as a quality-of-life issue in isolation — a prescription, a recommendation to try again — it is worth asking whether anyone has looked at the full picture.
If This Resonates — What to Do Next
If you are a man in your 40s, 50s or 60s with erection problems that have been partially treated or left unexplained, the most useful thing you can do is get a proper assessment — one that looks at the cardiovascular picture alongside everything else.
It does not need to be alarming. Most of what I am describing is a consultation, a blood panel, and in some cases a CT scan. The appointments are unhurried, the clinic at Devonshire Place is quiet and discreet, and the vast majority of men leave with a much clearer sense of what is actually going on and what can be done about it.
You can book an initial consultation directly. If you are unsure whether this is the right place to start, you are welcome to get in touch and I will do my best to point you in the right direction — whether that ends up being with me or elsewhere.
Common Questions
Can erectile dysfunction predict a heart attack?
It can be an early warning sign. Because the penile arteries are smaller than the coronary arteries, vascular disease affects them first — which is why erectile dysfunction often precedes a cardiovascular diagnosis by two to five years. Not every case of ED is vascular, but every man over 40 with erection problems should have his cardiovascular risk properly assessed.
Does erectile dysfunction in younger men matter more?
In relative terms, yes. Large meta-analyses show the cardiovascular risk signal from ED is strongest in younger men, because alternative explanations are fewer. Erection problems in your 30s or 40s, particularly without obvious risk factors, warrant investigation rather than just a prescription.
What tests should I have if I have erection problems?
At minimum: blood pressure, BMI and waist measurement, a full lipid profile (ideally including lipoprotein(a) and ApoB), HbA1c, hsCRP, testosterone and thyroid function. For men at low-to-intermediate cardiovascular risk, the Princeton IV guidelines also support a CT coronary artery calcium score.
Is it safe to take Viagra if I might have heart disease?
For most men, yes — and recent evidence suggests PDE5 inhibitors may even carry cardiovascular benefits for some. But this is exactly why assessment should come first: certain cardiac conditions and medications (particularly nitrates) change the answer, and the Princeton IV guidelines set out when cardiology input is needed before treatment.
Summary
Erectile dysfunction often precedes cardiovascular disease by two to five years, because penile arteries (1–2 mm) are affected by vascular disease earlier than coronary arteries (3–4 mm).
Meta-analyses consistently show men with erectile dysfunction have a significantly higher risk of heart attack, stroke, and all-cause mortality — independent of other known risk factors.
The shared mechanism is endothelial dysfunction: impaired nitric oxide signalling that affects vascular health throughout the body.
The Princeton IV Consensus (2023) recommends that erectile dysfunction be treated as a cardiovascular risk-enhancing factor, and supports coronary artery calcium scoring for risk stratification.
A thorough assessment of erectile dysfunction in men over 40 should always include cardiovascular evaluation — not as an afterthought, but as a central part of care.
References
1. Montorsi P, Ravagnani PM, Galli S, et al. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. European Urology. 2006;50(4):721–731.
2. Vlachopoulos C, Jackson G, Stefanadis C, Montorsi P. Erectile dysfunction in the cardiovascular patient. European Heart Journal. 2013;34(27):2034–2046.
3. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (The Second Princeton Consensus Conference). American Journal of Cardiology. 2005;96(2):313–321.
4. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. Journal of the American College of Cardiology. 2011;58(13):1378–1385.
5. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes. 2013;6(1):99–109.
6. Martínez-Salamanca JI, Cortes I, Portillo L, et al. Erectile dysfunction as a novel biomarker for the onset of cardiometabolic vascular disease risk in the aging male: a systematic review and meta-analysis. medRxiv [preprint]. 2024. doi:10.1101/2024.07.06.24310031
7. Köhler TS, Kloner RA, Rosen RC, et al. The Princeton IV consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clinic Proceedings. 2024;99(9):1500–1517.
8. Yamada T, Hara K, Umematsu H, Suzuki R, Kadowaki T. Erectile dysfunction and cardiovascular events in diabetic men: a meta-analysis of observational studies. PLOS ONE. 2012;7(9):e43673.
9. Soulaidopoulos S, Terentes-Printzios D, Ioakeimidis N, Tsioufis KP, Vlachopoulos C. Long-term effects of phosphodiesterase-5 inhibitors on cardiovascular outcomes and death: a systematic review and meta-analysis. European Heart Journal — Cardiovascular Pharmacotherapy. 2024;10(5):403–412.
Dr Ben Davis is a private men's health GP, physician and COSRT-registered psychosexual and relationship therapist based at Central Health London, Devonshire Place, Marylebone. He holds MRCGP, MRCP, FECSM and a PhD in men's emotional and sexual health, and is to his knowledge the only clinician in the UK who combines dual medical training with registered psychosexual therapy and a dedicated focus on men's health.
